Cargando…
Practical Aspects of Risk Assessment in Gastrointestinal Stromal Tumors
INTRODUCTION: Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors of the gastrointestinal tract, which are characterized in the majority of cases by activating mutations in KIT and platelet-derived growth factor receptor alpha (PDGFRA). The introduction of tyrosine kinase inhibitors has r...
Autor principal: | Jones, R. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126997/ https://www.ncbi.nlm.nih.gov/pubmed/24802226 http://dx.doi.org/10.1007/s12029-014-9615-x |
Ejemplares similares
-
Gastrointestinal Mesenchymal Neoplasms other than Gastrointestinal Stromal Tumors: Focusing on Their Molecular Aspects
por: Plesec, Thomas P.
Publicado: (2011) -
Gastrointestinal stromal tumor
por: Stamatakos, Michael, et al.
Publicado: (2009) -
Gastrointestinal stromal tumors
por: Beham, Alexander W., et al.
Publicado: (2011) -
Targeting gastrointestinal stromal tumors: the role of regorafenib
por: Schroeder, Brett, et al.
Publicado: (2016) -
Clinical practice guidelines for patients with gastrointestinal stromal tumor in Taiwan
por: Yeh, Chun-Nan, et al.
Publicado: (2012)